Singapore Paincare FY revenue rises amid GP clinic growth; swings to profit

Singapore Paincare Holdings

28/08/2026 16:16

Overview
Singapore pain management provider's full-year revenue rose 5.4% yr/yr to S$27.38 mln
Company posted net profit of S$42,000, reversing prior-year net loss

Outlook
Company did not provide specific financial guidance or outlook in the provided materials in the press release

Result Drivers
IMPAIRMENT LOSSES - Lower impairment losses on goodwill and investments contributed to the swing to profitability
GP CLINIC GROWTH – Revenue rose 5.4% to S$27.38 mln as new GP clinics and organic growth offset lower specialist and allied-health revenue
 
LOWER REBRANDING COSTS – Other expenses fell S$0.69 mln as marketing and consultancy spending declined after FY2025 rebranding initiatives ended
 
PUXIANG FAIR-VALUE GAIN – Share of joint-venture results swung to a S$0.32 mln gain from a S$0.73 mln loss, mainly due to a fair-value gain on its Puxiang investment

Company press release: ID:nSN720mXX

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
 
S$27.4 mln
 
FY Net Income
 
S$42,000
 

Reuters Recommended Reads
Aug 26 - Singapore's Alliance Healthcare FY revenue rises 13%
Aug 26 - Singapore's Thomson Medical Group FY revenue rises on Singapore strength, Malaysia oncology contribution
Aug 27 - Implant maker Aurora Spine's Q2 revenue falls, net loss widens on pain market weakness

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)